Zydus Pharmaceuticals (USA) Inc. is recalling 12,720 vials of Micafungin (micafungin) for injection, USP, 100 mg/vial. This medication is used to treat various fungal infections. The recall was initiated because the product may have been cross-contaminated with other products during the manufacturing process. Affected products were sold under both the Zydus Pharmaceuticals and Northstar Rx LLC brand names.
Cross-contamination with other drug products can lead to unintended exposure to different medications, which may cause adverse reactions or reduce the effectiveness of the treatment.
Distributed by Zydus Pharmaceuticals (USA) Inc.
Manufactured for Northstar Rx LLC.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.